Skip to main content
OpenTrials
Completed

NCT Number: NCT04884178

PMCF Study of Preloaded Trifocal IOL

This is a study to evaluate the safety, effectiveness and patient satisfaction of the Trifocal Intraocular Lens after implanted to replace the natural lens following cataract removal.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chang Gung Memorial Hospital, Linkou

Taoyuan, Taiwan

About this study

This study is a single-arm unmasked clinical evaluation study of safety, effectiveness and patient satisfactions of the Trifocal Intraocular Lens after successful bilateral cataract surgery. Subjects will be assessed pre-operative, operative date and at 1-2 days, 1-2 weeks, 1-2 months, 3-4 months and 6 months post-operative. Clinical evaluations will include probability of adverse events, patient satisfaction questionnaire, as well as measurements of monocular and bilateral far, intermediate and near visual acuity as a result of Trifocal Lens performance, etc.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Bilateral cataracts: Adults, 20 years of age or older at the time of informed consent, of either gender, diagnosed with bilateral cataracts
  • Desire for high post-operative spectacle independence
  • Willingness to cooperate with and complete all post-operative visits
  • Calculated lens power within +5.0 D and +34.0 D
  • Planned cataract removal by phacoemulsification
  • Clear intraocular media other that cataracts in both eyes
  • Potential post-operative visual acuity of 20/25 or better
  • Ability to comprehend and sign an informed consent
  • Signed informed consent

Exclusion criteria

  • More than 1.0 D of pre-operative corneal astigmatism
  • Expected post-operative astigmatism of more than 0.75 D
  • Mature/dense cataract which makes the pre-operative fundus examination difficult
  • Previous ocular surgery or trauma
  • Clinically significant irregular astigmatism
  • Choroidal hemorrhage
  • Microphthalmos
  • Severe corneal dystrophy
  • Medically controlled or uncontrolled glaucoma
  • Clinically significant macular/RPE changes
  • Concomitant severe eye disease
  • Severe optic nerve atrophy
  • Diabetic retinopathy, proliferative or macular edema
  • Amblyopia
  • Extremely shallow anterior chamber
  • Chronic sever uveitis
  • Pregnant or lactating
  • Previous retinal detachment
  • Previous corneal transplant
  • Concurrent participation in another drug or device investigation
  • May be expected to require other ocular surgery during the study

Treatment and study plan

Trifocal Preloaded IOL Delivery System

Device

UV and blue-light filtering foldable trifocal IOL with a +2.2 diopter (D) addition power of intermediate visual acuity and a +3.3 D addition power of near visual acuity. This device is approved in Taiwan.

Other names: Asqelio Trifocal, TFPIO130Y, TFLIO130, aspicio Trifocal, PTF60Y, TF60

Primary outcomes

  1. Photopic monocular CDVA, 400 cm

    Time frame: 6 Months post second eye implantation

  2. Photopic monocular CIVA, 60 cm

    Time frame: 6 Months post second eye implantation

  3. Photopic monocular CNVA, 40 cm

    Time frame: 6 Months post second eye implantation

  4. Rates of adverse events vs. ISO 11979-7:2018 SPE rate

    Time frame: 6 Months post second eye implantation

Sponsors and collaborators

Lead sponsor

ICARES Medicus, Inc.

Industry

Collaborators

  • AST Products, Inc.

Registry information

Official study title

Post-Market Clinical Follow-up Study of Preloaded Trifocal IOL Delivery System

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
May 12, 2021
Registry last updated
Apr 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.